Evaluating the safety and efficacy of thalamic DBS in treating traumatic brain injury

The safety and efficacy of deep brain stimulation.

Emergent cuts 300 jobs and shuts down two facilities in cost-cutting drive – Pharmaceutical Technology

Shares in the biotech are currently down around 98.5% compared to highs in August 2020, when plans for the manufacturing of potential vaccines and Covid-19

May 2, 2024

Mirum expands rare disease portfolio with digestive disorder drugs – Pharmaceutical Technology

Mirum Therapeutics acquired two bile disorder drug products from Travere Therapeutics. Credit: peakSTOCK via Getty Images. California-based biotech Mirum Therapeutics has announced the completion of

September 6, 2023

When it comes to policing pharma, the FTC says it’s on ‘an incredible winning streak’

Over the past two years, the U.S. Federal Trade Commission has attempted to crack down on the pharmaceutical industry over concerns that drug companies too

January 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.